GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $204,000 | -1.0% | 4,660 | 0.0% | 0.10% | +20.0% |
| Q1 2022 | $206,000 | -1.0% | 4,660 | 0.0% | 0.08% | -1.2% |
| Q4 2021 | $208,000 | +2.0% | 4,660 | -17.7% | 0.08% | -22.9% |
| Q1 2021 | $204,000 | -7.7% | 5,660 | +21.5% | 0.10% | -16.0% |
| Q4 2019 | $221,000 | +10.0% | 4,660 | 0.0% | 0.12% | -7.4% |
| Q3 2019 | $201,000 | -8.2% | 4,660 | -9.7% | 0.14% | -6.2% |
| Q1 2019 | $219,000 | +6.8% | 5,160 | 0.0% | 0.14% | -1.4% |
| Q4 2018 | $205,000 | -4.7% | 5,160 | 0.0% | 0.15% | +8.1% |
| Q3 2018 | $215,000 | +4.9% | 5,160 | 0.0% | 0.14% | -7.5% |
| Q1 2018 | $205,000 | 0.0% | 5,160 | -7.9% | 0.15% | -28.4% |
| Q4 2017 | $205,000 | -61.1% | 5,605 | -56.3% | 0.20% | -61.5% |
| Q3 2017 | $527,000 | -3.8% | 12,822 | -5.7% | 0.53% | -4.7% |
| Q2 2017 | $548,000 | -3.9% | 13,604 | 0.0% | 0.56% | -9.9% |
| Q1 2017 | $570,000 | +7.3% | 13,604 | 0.0% | 0.62% | -13.1% |
| Q4 2016 | $531,000 | – | 13,604 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |